Lotemax and Eye discharge - a phase IV clinical study of FDA data

Summary:

Eye discharge is reported as a side effect among people who take Lotemax (loteprednol etabonate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Restasis, and have Eye irritation.

The phase IV clinical study analyzes which people have Eye discharge when taking Lotemax. It is created by eHealthMe based on reports of 4,356 people who have side effects when taking Lotemax from the FDA, and is updated regularly.

What is Lotemax?

Lotemax has active ingredients of loteprednol etabonate. It is often used in inflammation. eHealthMe is studying from 4,431 Lotemax users. Check the latest studies of Lotemax.

What is Eye discharge?

Eye discharge is found to be associated with 688 drugs and 802 conditions by eHealthMe. Check the latest studies of Eye discharge.

On Jul, 27, 2026

4,356 people reported to have side effects when taking Lotemax.
Among them, 72 people (1.65%) have Eye discharge.

Among these 72 people:

How long have people been on Lotemax when they have Eye discharge? *

What is the gender of people who have Eye discharge when taking Lotemax? *

female: 84.51 %
male: 15.49 %

What is the age of people who have Eye discharge when taking Lotemax? *

What are other drugs people take besides Lotemax? *

What are other side effects people have besides Eye discharge? *

Ocular Hyperaemia (an abnormally large amount of blood in eye): 22 people, 30.56%
Eye Pain: 19 people, 26.39%
Eye Irritation: 16 people, 22.22%
Vision Blurred: 15 people, 20.83%
Eye Swelling: 12 people, 16.67%
Lacrimation Increased: 10 people, 13.89%
Eye Pruritus (eye itching): 9 people, 12.50%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 7 people, 9.72%
Foreign Body Sensation In Eyes (feeling of something in eye): 6 people, 8.33%
Visual Impairment: 6 people, 8.33%

What are the existing conditions these people have? *

Conjunctivitis (pink eye): 6 people, 8.33%
Eye Irritation: 6 people, 8.33%
Eye Inflammation: 5 people, 6.94%
High Blood Pressure: 5 people, 6.94%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 4 people, 5.56%
Giant Papillary Conjunctivitis (inner surface of the eyelids becomes irritated and inflamed): 4 people, 5.56%
Blepharitis (chronic inflammation of the eyelid): 4 people, 5.56%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 4 people, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 2.78%
Eye Allergy: 2 people, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Lotemax and have Eye discharge?

- Check whether Eye discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lotemax:

Lotemax (4,431 reports)

Eye discharge treatments and more:

Eye discharge (10,525 reports)

Browse all side effects of Lotemax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye discharge:

Eye discharge (688 drugs)

Browse all the conditions that are associated with Eye discharge:

Eye discharge (802 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loteprednol etabonate (the active ingredients of Lotemax) and Lotemax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.